Determination of EkoSonic Endovascular System Treatment According to Patient Characteristics in High-risk Pulmonary Embolism Patients

Basit Öğe Kaydı
dc.contributor.authorSelçuk, Nehir
dc.contributor.authorAlbeyoğlu, Şebnem
dc.contributor.authorSelçuk, İsmail
dc.contributor.authorŞimşek, Mustafa
dc.contributor.authorYılmaz, Ahmet Turan
dc.date.accessioned2024-07-12T22:04:24Z
dc.date.available2024-07-12T22:04:24Z
dc.date.issued2022en_US
dc.description.abstractObjectives: Pulmonary embolism (PE) is the third most common cause of cardiovascular death. The EkoSonic Endovascular System is one of the treatments for thrombus. In this study, it was aimed to investigate the re- sults of ECOS treatment and the effects of personal characteristics such as age, gender, and clinical history on the effectiveness and safety of treatment in patients with high or moderately high-risk PE. Methods: In this study, 51 patients who underwent ECOS with the diagnosis of medium-high-risk PE were analyzed retrospectively. Arte- rial blood gas oxygen saturation, partial oxygen pressure (PaO2) val- ues, RV diameters, pulmonary arterial pressure (PAPs), and tricuspid regurgitation in echocardiography and Qanadli Score in computed tomography were recorded in all patients before and after the proce- dure. In addition, PE and deep vein thrombosis localization, complete blood count, hemoglobin, hematocrit, platelet count, urea, creatinine values, minor and major bleeding, recurrent venous thromboembolism, and presence of complications were evaluated. All the data obtained were compared in male and female groups, in the over 65 age group and in groups classified according to the history of the underlying disease. Results: In all patients, the mean of saturation and PaO2 after the procedure was higher than before the procedure, the averages of he- moglobin, hematocrit, creatine, right ventricular (RV) diameter, PAP, and Qanad value were found to be lower than before the procedure (p<0.05). The RV diameter difference before and after the procedure was found to be higher in patients over 65 years of age than in pa- tients under 65 years of age (p<0.05). Considering the gender distribu- tion of ten patients with complications, 1 (10%) of the patients were male and 9 (90%) were female. Conclusion: This study shows that ECOS is an effective treatment op- tion in patients with high-risk PE.en_US
dc.identifier.doi10.14744/GKDAD.2022.26986
dc.identifier.endpage325en_US
dc.identifier.issn2548-0669
dc.identifier.issue4en_US
dc.identifier.startpage318en_US
dc.identifier.trdizinid1166488en_US
dc.identifier.urihttps://doi.org/10.14744/GKDAD.2022.26986
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1166488
dc.identifier.urihttps://hdl.handle.net/20.500.12415/9729
dc.identifier.volume28en_US
dc.indekslendigikaynakTR-Dizin
dc.language.isoenen_US
dc.relation.ispartofGöğüs Kalp Damar Anestezi ve Yoğun Bakım Derneği Dergisien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKY05093
dc.titleDetermination of EkoSonic Endovascular System Treatment According to Patient Characteristics in High-risk Pulmonary Embolism Patientsen_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu